Entresto for Hypertension? Yes!

ACC Conference Reporter

ESC 2015 | LONDON — Valsartan/sacubitril, formerly known as LCZ696 — but now bearing the brand name Entresto since it won FDA approval for heart failure — may also be a potent treatment for isolated systolic hypertension, the number one driver of stroke, researchers said here. Read More >>>

Keywords: ESC Congress


< Back to Listings